Alice Park is the senior health correspondent with TIME and author of The Stem Cell Hope, How Stem Cell Medicine Can Change Our Lives. In 2019, she co-chaired the inaugural Time 100 Health Summit. She has written cover stories on stem cells, childhood vaccinations, the health care system, heart disease, HIV, cancer immunotherapy and the gene editing technology CRISPR. She contributed to TIME’s coverage of the COVID-19 pandemic, focusing on the race to develop effective vaccines. Park also contributes to the magazine’s Olympics coverage, covering figure skating, gymnastics and swimming. She is the recipient of the 2021 New York Press Club Award for Feature Reporting — Science, Medicine & Technology for her story “How Remdesivir Moved From Back Shelf to Best Hope for Treating COVID-19,” and nominated for a 2022 Deadline Club Award for Science, Technology, Medical or Environmental Reporting for “The Miracle Workers.”Park has appeared on CNN, BBC America, NPR and Good Morning America, and has served on and hosted panels exploring public health issues, cancer, neuroscience and the role of the media in reporting medical news.
